Syon Capital LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Syon Capital LLC
- $1.23 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
349Shares Held
62.3MCall Options Held
5.66MPut Options Held
2.51M-
Vanguard Group Inc Valley Forge, PA7.08MShares$326 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$259 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$134 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$119 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$98.8 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.88B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...